By Counterforce Health Team in Emflaza (deflazacort) —

How to Get Emflaza (Deflazacort) Covered by Blue Cross Blue Shield in Michigan: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Emflaza Covered by Blue Cross Blue Shield Michigan

Eligibility: Patients 2+ years with genetically confirmed Duchenne muscular dystrophy (DMD) can get Emflaza covered by Blue Cross Blue Shield of Michigan through prior authorization. Fastest path: Submit PA request with DMD diagnosis, elevated creatinine kinase (10x upper limit), and absence of active infection. Start today: Contact your neurologist to initiate the prior authorization process using BCBSM's PA guidelines. Appeals must be filed within 180 days if denied, with external review available through Michigan DIFS within 127 days.

Table of Contents

  1. Coverage Requirements at a Glance
  2. Step-by-Step: Fastest Path to Approval
  3. Michigan Prior Authorization Laws and Your Rights
  4. Appeals Playbook for Blue Cross Blue Shield Michigan
  5. Common Denial Reasons and How to Fix Them
  6. Scripts and Templates for Success
  7. When to Escalate to Michigan DIFS
  8. Costs and Patient Support Programs
  9. FAQ: Your Top Questions Answered

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for all Emflaza prescriptions BCBSM formulary PA Guidelines
Age Requirement Patient must be 2+ years old FDA labeling Emflaza Prescribing Info
DMD Diagnosis Genetically confirmed Duchenne muscular dystrophy Clinical documentation BCBSM PA Criteria
Lab Requirements Creatinine kinase 10x upper normal limit Pre-treatment labs PA Requirements
Infection Screening No active TB or hepatitis B Medical records Clinical Guidelines
Initial Authorization 6 months coverage PA approval letter BCBSM Policy
Renewal Authorization 12 months with clinical benefit Motor function assessments BCBSM Policy

Step-by-Step: Fastest Path to Approval

1. Confirm Your Diagnosis and Eligibility

Who does it: Your neurologist or neuromuscular specialist
Documents needed: Genetic test results confirming DMD, recent creatinine kinase levels
Timeline: 1-2 days to gather records
Key point: BCBSM requires specialist management and genetic confirmation of DMD

2. Complete Pre-Authorization Screening

Who does it: Your healthcare team
Documents needed: TB screening, hepatitis B testing, current infection status
Timeline: 3-5 days for lab results
Submit via: Provider portal or fax to BCBSM PA department

3. Submit Prior Authorization Request

Who does it: Your prescribing physician's office
Documents needed: PA form, clinical notes, lab results, genetic testing
Timeline: BCBSM has 15 business days for non-urgent requests
Submit via: BCBSM provider portal or PA fax line

4. Track Your Request Status

Who does it: You or your clinic
How to check: Call BCBSM member services or check online portal
Timeline: Check after 10 business days if no response
Phone: Member services number on your insurance card

5. If Denied, File Internal Appeal Immediately

Who does it: You, with your doctor's support
Documents needed: Denial letter, medical necessity letter, updated clinical notes
Timeline: Must file within 180 days of denial notification
Submit via: BCBSM appeals form

6. Request Expedited Review if Urgent

Who does it: Your physician
Documents needed: Letter stating medical urgency and risk of delay
Timeline: BCBSM must respond within 72 hours
Key requirement: Physician must substantiate that delay would jeopardize health

7. Prepare for External Review if Needed

Who does it: You, with clinical support
Documents needed: Final denial letter, complete medical records
Timeline: File within 127 days of final internal denial
Submit to: Michigan DIFS external review

Michigan Prior Authorization Laws and Your Rights

Michigan's insurance regulations provide strong consumer protections that work alongside your Blue Cross Blue Shield plan policies. Understanding these state rules can significantly improve your chances of getting Emflaza approved.

Turnaround Standards and Deadlines

Non-Urgent Prior Authorization: BCBSM must respond within 15 business days of receiving a complete request. If additional information is needed, they have 10 additional days once you provide it.

Urgent Prior Authorization: When your physician certifies that a delay would seriously jeopardize your health, BCBSM must respond within 72 hours.

Renewal Timelines: For ongoing Emflaza therapy, submit renewal requests 30-45 days before your current authorization expires to avoid treatment interruptions.

Step Therapy Protections

Michigan law allows medical exceptions to step therapy requirements. For Emflaza, this is particularly relevant since some plans may require trying prednisone first. You can request a step therapy override if:

  • You've previously tried and failed prednisone or prednisolone
  • You have a medical contraindication to standard corticosteroids
  • Your physician documents that Emflaza is more appropriate for your specific clinical situation

Continuity of Care Rights

If you're already on Emflaza and switch to a new BCBSM plan, Michigan law provides transition protections. You may be entitled to temporary coverage while the new plan processes your prior authorization, especially for chronic conditions like DMD.

Appeals Playbook for Blue Cross Blue Shield Michigan

When BCBSM denies your Emflaza request, Michigan's appeal process gives you multiple opportunities to overturn the decision. Here's your complete roadmap:

Internal Appeal (First Level)

Timeline: File within 180 days of denial
Response time: 60 days for standard review, 72 hours for expedited
Required documents:

  • Original denial letter
  • Medical necessity letter from your neurologist
  • Updated clinical notes showing DMD progression
  • Any new lab results or functional assessments

Submit via: BCBSM appeals form or written letter to the address on your denial notice

Peer-to-Peer Review

Before or during your internal appeal, request a peer-to-peer review where your neurologist speaks directly with BCBSM's medical director. This often resolves denials quickly when the reviewing physician understands the clinical nuances of DMD treatment.

External Review (Final Level)

Timeline: File within 127 days of final internal denial
Response time: 56 days (can extend to 84 days for complex cases)
Decision: Binding on BCBSM
Submit to: Michigan Department of Insurance and Financial Services (DIFS)

Required forms: DIFS External Review Request (FIS 0018)

Contact DIFS: 877-999-6442 for assistance with your external review

From our advocates: We've seen DMD families succeed by emphasizing the FDA approval of Emflaza specifically for DMD and including motor function data showing disease progression. One family's external review was approved after they documented that prednisone caused significant weight gain and mood changes that Emflaza avoided, improving quality of life while maintaining therapeutic benefit.

Common Denial Reasons and How to Fix Them

Denial Reason How to Overturn Required Documentation
"Not medically necessary" Emphasize FDA approval for DMD, include clinical guidelines FDA label, neurologist letter, motor function tests
"Step therapy required" Request medical exception with contraindication to prednisone Prior treatment history, side effect documentation, physician attestation
"Experimental/investigational" Cite FDA approval and standard-of-care status FDA approval letter, DMD treatment guidelines, peer-reviewed studies
"Age restriction" Confirm patient is 2+ years old Birth certificate, medical records confirming age
"Diagnosis not supported" Provide genetic testing confirmation Genetic test results, muscle biopsy if available, specialist consultation notes

Scripts and Templates for Success

Patient Phone Script for BCBSM

"Hi, I'm calling about prior authorization for Emflaza for my [child/family member] with Duchenne muscular dystrophy. The request was submitted on [date] by Dr. [name]. Can you tell me the status and what additional information might be needed? The FDA approved Emflaza specifically for DMD, and my neurologist says it's medically necessary."

Medical Necessity Letter Template

Your neurologist should include these key elements:

  • Patient identification: Name, DOB, insurance ID, DMD diagnosis with ICD-10 code G71.0
  • Clinical justification: "Emflaza is FDA-approved for DMD and represents standard of care for corticosteroid treatment in this population"
  • Specific medical need: Document current functional status, disease progression, and why Emflaza is preferred over alternatives
  • Supporting evidence: Reference FDA labeling, DMD care guidelines, and any relevant clinical studies

Sample paragraph: "This patient has genetically confirmed Duchenne muscular dystrophy and meets all FDA-approved criteria for Emflaza treatment. Creatinine kinase levels are elevated at [X times] the upper limit of normal, confirming active muscle damage. Emflaza's improved side effect profile compared to prednisone is particularly important for long-term management in DMD patients."

When to Escalate to Michigan DIFS

If BCBSM denies your internal appeal, don't give up. Michigan's Department of Insurance and Financial Services provides independent external review that's often more favorable to patients than internal insurance company reviews.

File external review when:

  • Internal appeal is denied
  • BCBSM fails to respond within required timeframes
  • You believe the denial violates Michigan insurance law or your policy terms

What to include:

  • Completed DIFS external review form
  • All denial letters and correspondence
  • Complete medical records supporting Emflaza medical necessity
  • Physician letter explaining urgency if applicable

DIFS contact: 877-999-6442, Monday-Friday, 8 a.m. to 5 p.m.

The external review decision is binding on BCBSM, giving you a final opportunity to secure coverage through an independent medical review.

Costs and Patient Support Programs

While working through the approval process, explore these cost-saving options:

PTC Therapeutics Patient Support: The manufacturer offers copay assistance and patient access programs. Contact them at 1-877-PTC-1234 for eligibility screening.

Muscular Dystrophy Association (MDA): Provides grants and advocacy support for DMD families. Visit mda.org for resources specific to Michigan.

GoodRx pricing: Discount prices for Emflaza 6mg tablets range from $9-12 per tablet, though actual costs vary by pharmacy and strength.

FAQ: Your Top Questions Answered

How long does BCBSM prior authorization take for Emflaza? Standard requests: 15 business days. Urgent requests: 72 hours with physician certification of medical urgency.

What if Emflaza isn't on BCBSM's formulary? You can request a formulary exception with medical necessity documentation. BCBSM must review exception requests even for non-covered drugs.

Can I get expedited approval if my child is losing function? Yes. Your neurologist must provide written certification that delay would jeopardize health or ability to regain maximum function.

Does step therapy apply if we tried prednisone outside Michigan? Yes, prior treatment history from any state counts. Document the previous trial, duration, and reasons for discontinuation.

What happens if the external review is denied? DIFS external review decisions are final and binding. However, you may have additional options through federal appeals if your plan is subject to ERISA.

How do I prove my child has DMD for the PA request? Include genetic testing results, muscle biopsy reports if available, and specialist consultation notes confirming the diagnosis.

About Counterforce Health: Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals. Our platform analyzes denial letters and creates targeted, evidence-backed rebuttals that align with each payer's specific requirements, significantly improving approval rates for specialty medications like Emflaza.

Sources and Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance policies vary, and coverage decisions depend on individual circumstances. Always consult with your healthcare provider and insurance plan directly for guidance specific to your situation. For additional help with insurance appeals in Michigan, contact the Michigan Department of Insurance and Financial Services at 877-999-6442.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.